$1.110
-0.048 (-4.31%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LCTX Prediction & Forecast by Similar Chart Analysis
Alphio's LCTX stock price prediction model matches the current Lineage Cell Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.11 (-0.07%). The 1-week path is $1.10 (-0.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Lineage Cell Therapeutics Inc Stock?
Lineage Cell Therapeutics Inc (LCTX) appears to be a good buy right now due to its current price of $1.11, which is significantly below the analyst price target of $9 from Canaccord. Additionally, the gross margin stands at an impressive 100% for the most recent quarter, indicating strong profitability potential. However, the main risk is the forward P/E ratio of 30.67, suggesting that the stock may be overvalued based on future earnings expectations.
LCTX stock price ended at $1.11 on Friday, after losing -4.31%
Lineage Cell Therapeutics Inc (LCTX) last closed at $1.11, losing -4.31%. These facts feed the 1-day and 1-week LCTX price prediction above.
Forecast Drivers
Lineage Cell Therapeutics Inc (LCTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LCTX, ranked by similarity.
Seasonality analysis for LCTX
Historically the probability of a positive August return for LCTX is 33.33%. January offers the highest probability of a positive month at 72.13%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LCTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.15 | $1.32 | $1.62 | +18.93% |
| Sep 2026 | $0.80 | $1.01 | $1.27 | -8.66% |
| Oct 2026 | $1.24 | $1.27 | $1.54 | +14.57% |
| Nov 2026 | $0.99 | $1.10 | $1.33 | -0.90% |
| Dec 2026 | $1.09 | $1.34 | $1.35 | +20.46% |
In 2026, Lineage Cell Therapeutics Inc (LCTX) is projected to range from $0.80 to $1.62.
Lineage Cell Therapeutics Inc 2026 monthly forecast
In Aug 2026, Lineage Cell Therapeutics Inc is projected to average $1.32, with a low of $1.15 and high of $1.62.
In Sep 2026, Lineage Cell Therapeutics Inc is projected to average $1.01, with a low of $0.80 and high of $1.27.
In Oct 2026, Lineage Cell Therapeutics Inc is projected to average $1.27, with a low of $1.24 and high of $1.54.
In Nov 2026, Lineage Cell Therapeutics Inc is projected to average $1.10, with a low of $0.99 and high of $1.33.
In Dec 2026, Lineage Cell Therapeutics Inc is projected to average $1.34, with a low of $1.09 and high of $1.35.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.